Ivermectin may interact with drugs that affect the CYP3A4 enzyme system, such as certain antifungals or antiretrovirals. It is essential to inform your healthcare provider about all medicines you are taking so they can assess potential interactions and adjust doses if necessary.
Mild dizziness is a known, usually transient side effect. Sit or lie down until it resolves, stay hydrated, and avoid driving or operating heavy machinery until you feel stable. If dizziness persists or worsens, seek medical evaluation.
Ivermectin is generally contraindicated during pregnancy, especially in the first trimester, because safety data are limited. If treatment is absolutely required, a specialist must weigh the benefits against potential fetal risks.
Official ivermectin tablets bear clear imprint codes, dosage strength, and the manufacturer’s name on the packaging. Always obtain medication from a reputable pharmacy, check the blister pack for tamper-evidence, and verify the imprint against the product label.
Ivermectin may be taken with or without food. A high-fat meal can modestly increase absorption, but this does not significantly alter therapeutic effect. Follow any specific instructions provided by your prescriber.
Both tablets contain the same active ingredient; the 12 mg tablet simply provides a higher dose, useful for patients who require larger weight-based dosing. Your clinician will select the appropriate strength based on your body weight and the condition being treated.
Standard workplace or sporting drug tests do not target ivermectin, so false-positive results are highly unlikely. However, specialized tests in research settings could detect the drug if specifically screened for.
Early laboratory studies suggested antiviral activity against SARS-CoV-2, prompting interest in repurposing the drug. Large, well-controlled clinical trials have not confirmed a meaningful benefit, and health authorities have not approved ivermectin for COVID-19 treatment.
Keep the medication in its original container, protected from heat, moisture, and direct sunlight. Carry it in hand luggage to avoid temperature extremes in cargo holds, and retain the prescription label for customs verification if required.
Do not flush tablets down the toilet or discard them in household waste. Return unused medication to a pharmacy dispensing take-back program or follow NHS guidance for safe disposal to minimize environmental contamination.
Ivermectin is an antiparasitic medication available in pill form and supplied in strengths of 3 mg, 6 mg, and 12 mg. In the United Kingdom it is a prescription-only medicine regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). The drug is used to treat several parasitic infections and has been the subject of extensive public discussion regarding its potential role in COVID-19 management. This article provides an evidence-based overview of ivermectin’s pharmacology, approved and off-label uses, safety profile, dosing recommendations, and practical considerations for patients.
Ivermectin belongs to the macrocyclic lactone class of antiparasitics. After oral administration it is absorbed from the gastrointestinal tract, reaching peak plasma concentrations within 4-5 hours. The drug binds with high affinity to glutamate-gated chloride channels that are present in the nerve and muscle cells of many invertebrates. This binding increases the permeability of the cell membrane to chloride ions, causing hyperpolarisation, paralysis, and death of the parasite.
In humans, ivermectin has limited activity at mammalian glutamate-gated channels because of structural differences, which accounts for its relatively wide safety margin. The drug is metabolised primarily in the liver by cytochrome P450 enzymes (mainly CYP3A4) and is excreted in the feces. Its terminal half-life ranges from 12 to 36 hours, allowing once-daily dosing for most approved indications.
In the United Kingdom, ivermectin is approved for the following parasitic infections:
These indications are based on robust clinical trials demonstrating efficacy and safety when ivermectin is taken at the recommended doses for each condition.
Ivermectin has been investigated as a potential treatment for COVID-19, but regulatory agencies in the UK (MHRA) and internationally (FDA, EMA) have not approved it for this indication. The bulk of high-quality randomized controlled trials and meta-analyses have not demonstrated a clear clinical benefit that outweighs known risks.
Key points
Disclaimer: Off-label use of any medication requires medical supervision and individualized risk assessment.
Patients should disclose all prescription medicines, over-the-counter drugs, herbal supplements, and vitamins to their healthcare provider before starting ivermectin.
All doses must be calculated according to the patient’s weight and the available tablet strengths (3 mg, 6 mg, 12 mg).
This article provides educational information about ivermectin and is not a substitute for professional medical advice. Treatment decisions, including the use of ivermectin for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
